Benzinga's Top Pre-Market Gainers

Kythera Biopharmaceuticals (NASDAQ: KYTH ) shares jumped 28.69% to $43.15 in pre-market trading after the company reported positive ATX-101 top line phase III trial results for the reduction of submental fat. Huntsman (NYSE: HUN ) surged 8.05% to $20.68 in the pre-market session after the company announced its plans